FENTANYL CITRATE
| Brand name | LAZANDA |
|---|---|
| Active ingredient | FENTANYL CITRATE |
| Strength | EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Dosage form | SPRAY, METERED |
| Route | NASAL |
| Modality | Small molecule |
| FDA approval | June 2011 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 9731869 | January 2032 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.